What is the appropriate duration of adjuvant imatinib mesylate treatment for primary gastrointestinal stromal tumors classified according to the strict definition of tumor rupture?

In gastrointestinal stromal tumors (GISTs), rupture is a high-risk feature; however, “tumor rupture” is inconsistently defined, and its prognostic value remains controversial. Six hundred ninety-one patients undergoing surgery for primary nonmetastatic GISTs from 2003 to 2015 at our institution were...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jun, Dai, Yun, Zheng, Hua-Long, Xie, Jian-Wei, Wang, Jia-Bin, Lin, Jian-Xian, Chen, Qi-Yue, Cao, Long-Long, Lin, Mi, Tu, Ru-Hong, Huang, Ze-Ning, Lin, Ju-Li, Li, Ping, Huang, Chang-Ming, Zheng, Chao-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370173/
https://www.ncbi.nlm.nih.gov/pubmed/30653164
http://dx.doi.org/10.1097/MD.0000000000014177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370173/
https://www.ncbi.nlm.nih.gov/pubmed/30653164
http://dx.doi.org/10.1097/MD.0000000000014177

Ejemplares similares